Evidence map›Paper›PMID 34534697›Full record

ArticleJournal of biomedical informatics2021

Ranking sets of morbidities using hypergraph centrality.

James Rafferty, Alan Watkins, Jane Lyons, Ronan A Lyons, Ashley Akbari, Niels Peek, Farideh Jalali-Najafabadi, Thamer Ba Dhafari, Alexander Pate, Glen P Martin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

James RaffertyHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK. Electronic address: j.m.rafferty@swansea.ac.uk.
Alan WatkinsHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK.
Jane LyonsHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK.
Ronan A LyonsHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK.
Ashley AkbariHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK.
Niels PeekDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, UK; Alan Turing Institute, London, UK.
Farideh Jalali-NajafabadiCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Thamer Ba DhafariDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, UK.
Alexander PateDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, UK.
Glen P MartinDivision of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, UK.
Rowena BaileyHealth Data Research-UK, Swansea University, Singleton Park, Swansea SA1 8PP, UK.
Manchester Academic Health Science Centre · GBSwansea University · GBHealth Data Research UK · GB

Funding

British Heart FoundationMedical Research Council MR/R016615Medical Research Council MR/S027750/1Wellcome Trust
6 · The paper itself

Abstract

Multi-morbidity, the health state of having two or more concurrent chronic conditions, is becoming more common as populations age, but is poorly understood. Identifying and understanding commonly occurring sets of diseases is important to inform clinical decisions to improve patient services and outcomes. Network analysis has been previously used to investigate multi-morbidity, but a classic application only allows for information on binary sets of diseases to contribute to the graph. We propose the use of hypergraphs, which allows for the incorporation of data on people with any number of conditions, and also allows us to obtain a quantitative understanding of the centrality, a measure of how well connected items in the network are to each other, of both single diseases and sets of conditions. Using this framework we illustrate its application with the set of conditions described in the Charlson morbidity index using data extracted from routinely collected population-scale, patient level electronic health records (EHR) for a cohort of adults in Wales, UK. Stroke and diabetes were found to be the most central single conditions. Sets of diseases featuring diabetes; diabetes with Chronic Pulmonary Disease, Renal Disease, Congestive Heart Failure and Cancer were the most central pairs of diseases. We investigated the differences between results obtained from the hypergraph and a classic binary graph and found that the centrality of diseases such as paraplegia, which are connected strongly to a single other disease is exaggerated in binary graphs compared to hypergraphs. The measure of centrality is derived from the weighting metrics calculated for disease sets and further investigation is needed to better understand the effect of the metric used in identifying the clinical significance and ranked centrality of grouped diseases. These initial results indicate that hypergraphs can be used as a valuable tool for analysing previously poorly understood relationships and information available in EHR data.

Indexed as

Diabetes MellitusAdultChronic DiseaseCohort StudiesElectronic Health RecordsHumansMorbidityHypergraphMulti-morbidityNetwork analysis

Identifiers

PMID34534697
PMCPMC8524321
OpenAlexW3199093529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.